| Thirty drugs were withdrawn from the Chinese market between 1999 and 2021, with 14 drugs withdrawn during the stable Chinese drug surveillance period (2012–2021). |
| Robust evidence contributed to the drug withdrawal decisions following the development of pharmacovigilance programs in China. |
| The development of regulations and advanced passive and active systems has enhanced the pharmacovigilance in China. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.